Although generally being hepatoprotective, IL-22 actually aggravates disease in experimental hepatitis B virus infection which appears to be mediated by IL-22-driven expression of chemokines such as CXCL9 and CXCL10 (Zhang et al., 2011). Here, IL22 is linked to hepatitis B virus infection.